Our finding that patients with advanced melanoma have elevated levels of serum LDH3 and LDH4, but reduced levels of serum LDH1 and LDH2, has also been reported in the case of breast cancer and other solid malignancies [30,31]. Here, LDHC is linked to melanoma.